Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis



Rating:

Share or cite this content

Citations should be made in the following way:
D. Kalafatis (Stockholm, Sweden), A. Löfdahl (Lund, Sweden), P. Näsman (Stockholm, Sweden), L. Elowsson Rendin (Lund, Sweden), G. Westergren-Thorsson (Lund, Sweden), M. Sköld (Stockholm, Sweden). Released mediators in ex vivo 3D-model of lung fibrosis correspond to elevated serum biomarkers in IPF. 4333

Member's Comments

No comment yet.

Related content which might interest you: PP231 – Released mediators in ex vivo 3D-model of lung fibrosis correspond to elevated serum biomarkers in IPF Source: ERS Lung Science Conference 2021 Year: 2021 Clinically validated markers of the extracellular matrix remodelling are altered by potential anti-fibrotic compounds in a human lung fibrosis ex vivo model Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 Extracellular matrix biomarkers predict change in lung function in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis Year: 2020 Different concentrations of CCL18 in serum and BALF of ILDs: A marker of pulmonary inflammation? Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 PP102 – A serum biomarker reflecting human neutrophil elastase degraded calprotectin is elevated in COPD and IPF Source: ERS Lung Science Conference 2021 Year: 2021 Elevation of serum tumor markers in patients with interstitial lung disease Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Extracorporal photosensitation in bleomycin-induced lung injury decreases IL-10 protein levels in BAL but not the level of inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 82s Year: 2005 Plasma markers of oxidative protein damage do not correlate with lung function or COPD in smokers Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 Increased CCL18 production in interstitial lung diseases is associated with fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004 Identifying serum molecular biomarkers that distinguish emphysema and early fibrotic interstitial lung disease. Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Plasma levels of circulating cell-free DNA are increased in idiopathic pulmonary fibrosis but do not correlate with disease severity Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Human β-defensin 2 and interleukin-8 as potential serum markers of pulmonary emphysema Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Profiling of COPD and IPF cytokine responses in human lung Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Eosinophil cationic protein stimulates TGF-β1 release by human lung fibroblasts Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005 Serum periostin is not a good biomarker to identify Th2-driven inflammation in COPD Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo Source: Eur Respir J, 50 (2) 1602367; 10.1183/13993003.02367-2016 Year: 2017 Association of elevated CRP and IL-6 with rapid decline in lung function and exacerbation in tuberculosis destroyed lung Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 BALF cells expression phenotypes and cytokine levels in BALF supernatant in fibrosing interstitial lung diseases Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012